Sona Nanotech Inc C.SONA

Alternate Symbol(s): SNANF

Healthcare Biotechnology

Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and advanced biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of cetyltrimethylammonium bromide (CTAB), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company is focused on the development of a pre-clinical nanomedical therapy for the treatment of cancer using its biocompatible GNR.

CSE:SONA - Post by User

Sona Nanotech Inc

Bullboard Posts

Comment by AUSTIN48on Oct 16, 2020 10:30am

171 Views

Post# 31727892

RE:HC

Correct me if i am wrong but was it not 40 days for approval with Health Canada?The final submission was sent in at the end of August.
Assuming a 5 day work week at HC are we not at 35 days and counting?
I am betting we have an approval next week.
I do not buy in to the conspirator theory or FDA first theory.

There is no reason for Sona to not be approved.

Bullboard Posts

Quantum eMotion leaps by 20 per cent after Becton Dickinson deal